Simulations Plus, Inc. (SLP)
USD 24.41
(-4.96%)
USD 24.41
(-4.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 9.95 Million USD | -0.07% |
| 2023 | 9.96 Million USD | -20.2% |
| 2022 | 12.48 Million USD | 27.61% |
| 2021 | 9.78 Million USD | 4.82% |
| 2020 | 9.33 Million USD | 8.72% |
| 2019 | 8.58 Million USD | -3.93% |
| 2018 | 8.93 Million USD | 54.38% |
| 2017 | 5.78 Million USD | 16.92% |
| 2016 | 4.95 Million USD | 28.81% |
| 2015 | 3.84 Million USD | 27.02% |
| 2014 | 3.02 Million USD | 4.81% |
| 2013 | 2.88 Million USD | -4.67% |
| 2012 | 3.02 Million USD | 11.54% |
| 2011 | 2.71 Million USD | 25.91% |
| 2010 | 2.15 Million USD | 52.69% |
| 2009 | 1.41 Million USD | -18.17% |
| 2008 | 1.72 Million USD | 17.7% |
| 2007 | 1.46 Million USD | 116.92% |
| 2006 | 675.87 Thousand USD | 157.65% |
| 2005 | 262.31 Thousand USD | -68.64% |
| 2004 | 836.48 Thousand USD | -66.62% |
| 2003 | 2.5 Million USD | 416.8% |
| 2002 | 484.91 Thousand USD | 314.94% |
| 2001 | -225.6 Thousand USD | 12.42% |
| 2000 | -257.6 Thousand USD | 55.33% |
| 1999 | -576.66 Thousand USD | 72.13% |
| 1998 | -2.06 Million USD | -44.05% |
| 1997 | -1.43 Million USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.94 Million USD | 264.23% |
| 2024 Q3 | 3.13 Million USD | -22.14% |
| 2024 Q4 | 800 Thousand USD | -74.5% |
| 2024 Q2 | 4.02 Million USD | 107.15% |
| 2023 Q4 | 534 Thousand USD | -86.68% |
| 2023 Q1 | 1.24 Million USD | 29.55% |
| 2023 FY | 9.96 Million USD | -20.2% |
| 2023 Q2 | 4.17 Million USD | 235.26% |
| 2023 Q3 | 4 Million USD | -3.98% |
| 2022 Q1 | 3.02 Million USD | 892.13% |
| 2022 FY | 12.48 Million USD | 27.61% |
| 2022 Q4 | 961 Thousand USD | -76.49% |
| 2022 Q3 | 4.08 Million USD | -7.3% |
| 2022 Q2 | 4.4 Million USD | 45.7% |
| 2021 Q4 | 305 Thousand USD | -91.95% |
| 2021 Q1 | 2.47 Million USD | 13.29% |
| 2021 Q3 | 3.78 Million USD | 17.94% |
| 2021 Q2 | 3.21 Million USD | 29.53% |
| 2021 FY | 9.78 Million USD | 4.82% |
| 2020 Q4 | 2.18 Million USD | -25.46% |
| 2020 FY | 9.33 Million USD | 8.72% |
| 2020 Q1 | 2.05 Million USD | -0.05% |
| 2020 Q2 | 2.15 Million USD | 4.46% |
| 2020 Q3 | 2.93 Million USD | 36.53% |
| 2019 Q1 | 1.53 Million USD | 14.8% |
| 2019 Q2 | 2.09 Million USD | 36.69% |
| 2019 Q3 | 2.88 Million USD | 37.59% |
| 2019 Q4 | 2.05 Million USD | -28.71% |
| 2019 FY | 8.58 Million USD | -3.93% |
| 2018 Q4 | 1.33 Million USD | -44.39% |
| 2018 Q2 | 3.47 Million USD | 102.49% |
| 2018 FY | 8.93 Million USD | 54.38% |
| 2018 Q1 | 1.71 Million USD | 49.19% |
| 2018 Q3 | 2.4 Million USD | -30.76% |
| 2017 Q3 | 2.08 Million USD | 73.95% |
| 2017 Q2 | 1.19 Million USD | -12.18% |
| 2017 Q1 | 1.36 Million USD | 72.57% |
| 2017 FY | 5.78 Million USD | 16.92% |
| 2017 Q4 | 1.15 Million USD | -44.7% |
| 2016 FY | 4.95 Million USD | 28.81% |
| 2016 Q1 | 1.1 Million USD | 125.17% |
| 2016 Q2 | 1.14 Million USD | 3.51% |
| 2016 Q4 | 788.97 Thousand USD | -58.68% |
| 2016 Q3 | 1.9 Million USD | 66.7% |
| 2015 Q2 | 970.23 Thousand USD | 83.44% |
| 2015 Q1 | 528.9 Thousand USD | 137.26% |
| 2015 FY | 3.84 Million USD | 27.02% |
| 2015 Q3 | 1.85 Million USD | 90.93% |
| 2015 Q4 | 491.4 Thousand USD | -73.47% |
| 2014 Q3 | 1.3 Million USD | 61.45% |
| 2014 FY | 3.02 Million USD | 4.81% |
| 2014 Q1 | 685.15 Thousand USD | 179.88% |
| 2014 Q2 | 809.86 Thousand USD | 18.2% |
| 2014 Q4 | 222.92 Thousand USD | -82.95% |
| 2013 Q3 | 993.23 Thousand USD | -6.44% |
| 2013 FY | 2.88 Million USD | -4.67% |
| 2013 Q1 | 586.98 Thousand USD | 68.21% |
| 2013 Q2 | 1.06 Million USD | 80.85% |
| 2013 Q4 | 244.8 Thousand USD | -75.35% |
| 2012 Q3 | 869.33 Thousand USD | 3.67% |
| 2012 FY | 3.02 Million USD | 11.54% |
| 2012 Q1 | 971.02 Thousand USD | 423.39% |
| 2012 Q2 | 838.57 Thousand USD | -13.64% |
| 2012 Q4 | 348.95 Thousand USD | -59.86% |
| 2011 Q1 | 567.49 Thousand USD | 64.35% |
| 2011 Q3 | 1.05 Million USD | 16.16% |
| 2011 Q2 | 907.48 Thousand USD | 59.91% |
| 2011 Q4 | 185.52 Thousand USD | -82.4% |
| 2011 FY | 2.71 Million USD | 25.91% |
| 2010 FY | 2.15 Million USD | 52.69% |
| 2010 Q4 | 345.29 Thousand USD | -53.35% |
| 2010 Q3 | 740.11 Thousand USD | 15.49% |
| 2010 Q2 | 640.86 Thousand USD | 49.11% |
| 2010 Q1 | 429.8 Thousand USD | 163.43% |
| 2009 Q1 | 311.72 Thousand USD | 89.11% |
| 2009 Q4 | 163.15 Thousand USD | -71.33% |
| 2009 Q3 | 569.13 Thousand USD | 54.63% |
| 2009 FY | 1.41 Million USD | -18.17% |
| 2009 Q2 | 368.07 Thousand USD | 18.08% |
| 2008 FY | 1.72 Million USD | 17.7% |
| 2008 Q4 | 164.83 Thousand USD | -78.1% |
| 2008 Q3 | 752.66 Thousand USD | 33.26% |
| 2008 Q2 | 564.8 Thousand USD | 132.18% |
| 2008 Q1 | 243.26 Thousand USD | 524.8% |
| 2007 Q2 | 667.85 Thousand USD | 812.18% |
| 2007 Q3 | 782.29 Thousand USD | 17.13% |
| 2007 Q4 | -57.26 Thousand USD | -107.32% |
| 2007 FY | 1.46 Million USD | 116.92% |
| 2007 Q1 | 73.21 Thousand USD | -69.47% |
| 2006 Q1 | -198.53 Thousand USD | -443.93% |
| 2006 FY | 675.87 Thousand USD | 157.65% |
| 2006 Q3 | 386.13 Thousand USD | 55.41% |
| 2006 Q2 | 248.46 Thousand USD | 225.15% |
| 2006 Q4 | 239.8 Thousand USD | -37.9% |
| 2005 Q4 | 57.72 Thousand USD | -66.68% |
| 2005 FY | 262.31 Thousand USD | -68.64% |
| 2005 Q2 | 8836.00 USD | -60.74% |
| 2005 Q3 | 173.25 Thousand USD | 1860.73% |
| 2005 Q1 | 22.5 Thousand USD | -96.28% |
| 2004 Q1 | 46.71 Thousand USD | -97.75% |
| 2004 Q4 | 605.58 Thousand USD | 356.79% |
| 2004 Q3 | 132.57 Thousand USD | 306.33% |
| 2004 Q2 | 32.62 Thousand USD | -30.16% |
| 2004 FY | 836.48 Thousand USD | -66.62% |
| 2003 Q2 | 66.63 Thousand USD | -49.02% |
| 2003 Q1 | 130.71 Thousand USD | -11.35% |
| 2003 Q3 | 226.98 Thousand USD | 240.64% |
| 2003 Q4 | 2.07 Million USD | 815.83% |
| 2003 FY | 2.5 Million USD | 416.8% |
| 2002 Q4 | 147.44 Thousand USD | 35.22% |
| 2002 FY | 484.91 Thousand USD | 314.94% |
| 2002 Q3 | 109.03 Thousand USD | -49.97% |
| 2002 Q2 | 217.93 Thousand USD | 1974.35% |
| 2002 Q1 | 10.5 Thousand USD | 107.25% |
| 2001 FY | -225.6 Thousand USD | 12.42% |
| 2001 Q4 | -144.97 Thousand USD | -113.55% |
| 2001 Q3 | -67.89 Thousand USD | -2328.09% |
| 2001 Q2 | 3047.00 USD | 119.31% |
| 2001 Q1 | -15.77 Thousand USD | 83.13% |
| 2000 FY | -257.6 Thousand USD | 55.33% |
| 2000 Q1 | -42.95 Thousand USD | 84.47% |
| 2000 Q4 | -93.52 Thousand USD | 44.57% |
| 2000 Q3 | -168.73 Thousand USD | -454.35% |
| 2000 Q2 | 47.61 Thousand USD | 210.85% |
| 1999 Q2 | -200 Thousand USD | -100.0% |
| 1999 Q1 | -100 Thousand USD | 87.0% |
| 1999 FY | -576.66 Thousand USD | 72.13% |
| 1999 Q3 | - USD | 100.0% |
| 1999 Q4 | -276.66 Thousand USD | 0.0% |
| 1998 Q2 | -600 Thousand USD | -50.0% |
| 1998 FY | -2.06 Million USD | -44.05% |
| 1998 Q3 | -300 Thousand USD | 50.0% |
| 1998 Q4 | -769.23 Thousand USD | -156.41% |
| 1998 Q1 | -400 Thousand USD | 37.15% |
| 1997 FY | -1.43 Million USD | 0.0% |
| 1997 Q3 | -400 Thousand USD | -100.0% |
| 1997 Q2 | -200 Thousand USD | 0.0% |
| 1997 Q4 | -636.47 Thousand USD | -59.12% |
| 1997 Q1 | -200 Thousand USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 120.45% |
| Augmedix, Inc. | -19.17 Million USD | 151.922% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 106.438% |
| CareCloud, Inc. | -48.67 Million USD | 120.45% |
| HealthEquity, Inc. | 55.71 Million USD | 82.133% |
| iCoreConnect Inc. | -15.55 Million USD | 164.006% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 55.915% |
| Nutex Health, Inc. | -45.78 Million USD | 121.74% |
| Omnicell, Inc. | -20.37 Million USD | 148.864% |
| OneMedNet Corporation | -23.2 Million USD | 142.895% |
| Progyny, Inc. | 62.03 Million USD | 83.955% |
| Renalytix Plc | -33.45 Million USD | 129.753% |
| Schrödinger, Inc. | 40.72 Million USD | 75.555% |
| SOPHiA GENETICS SA | -78.98 Million USD | 112.603% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | 153.238% |
| Ontrak, Inc. | -27.92 Million USD | 135.652% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 99.365% |
| Sharecare, Inc. | -128.49 Million USD | 107.746% |
| Aclarion, Inc. | -4.91 Million USD | 302.672% |
| CareMax, Inc. | -683.34 Million USD | 101.457% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | 285.852% |
| Forian Inc. | 11.1 Million USD | 10.378% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | 285.852% |
| HeartBeam, Inc. | -14.63 Million USD | 167.996% |
| GeneDx Holdings Corp. | -175.76 Million USD | 105.663% |
| SCWorx Corp. | -3.98 Million USD | 350.029% |
| Minerva Surgical, Inc. | -34.11 Million USD | 129.18% |
| Definitive Healthcare Corp. | -202.38 Million USD | 104.918% |
| 10x Genomics, Inc. | -255.09 Million USD | 103.902% |
| Zhongchao Inc. | -11.33 Million USD | 187.809% |
| Accolade, Inc. | -99.8 Million USD | 109.973% |
| MSP Recovery, Inc. | -56.34 Million USD | 117.665% |
| R1 RCM Inc. | 3.3 Million USD | -201.636% |
| Spok Holdings, Inc. | 15.66 Million USD | 36.461% |
| Privia Health Group, Inc. | 23.07 Million USD | 56.87% |
| EUDA Health Holdings Limited | -10.03 Million USD | 199.149% |
| TruBridge, Inc. | -45.78 Million USD | 121.739% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 106.438% |
| Sharecare, Inc. | -128.49 Million USD | 107.746% |
| Health Catalyst, Inc. | -118.14 Million USD | 108.425% |
| GoodRx Holdings, Inc. | -8.86 Million USD | 212.246% |
| Premier, Inc. | 119.54 Million USD | 91.673% |
| HealthStream, Inc. | 15.21 Million USD | 34.569% |
| Certara, Inc. | -55.35 Million USD | 117.981% |
| GeneDx Holdings Corp. | -175.76 Million USD | 105.663% |
| Ontrak, Inc. | -27.92 Million USD | 135.652% |
| SHL Telemedicine Ltd. | -7.05 Million USD | 241.071% |
| CareCloud, Inc. | -48.67 Million USD | 120.45% |
| EUDA Health Holdings Limited | -10.03 Million USD | 199.149% |
| HeartBeam, Inc. | -14.63 Million USD | 167.996% |
| Mangoceuticals, Inc. | -9.21 Million USD | 208.05% |
| CareMax, Inc. | -683.34 Million USD | 101.457% |
| Healthcare Triangle, Inc. | -12.33 Million USD | 180.671% |
| National Research Corporation | 30.97 Million USD | 67.86% |
| Aclarion, Inc. | -4.91 Million USD | 302.672% |
| OptimizeRx Corporation | -17.56 Million USD | 156.667% |